Other languages Cellebrite DI Ltd.

Equities

CLBT

IL0011794802

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
10.55 ^USD	+0.29%		+0.29%	+21.82%

May. 24	JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating	MT
May. 24	Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cellebrite's Q1 Non-GAAP Earnings, Revenue Increase	May. 23
Cellebrite DI Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 23
Cellebrite Di Ltd. Provides Earnings Guidance for Second-Quarter of 2024 and Reaffirms Earnings Guidance for the Full Year 2024	May. 23
GNW-Adhoc: Cellebrite revolutioniert die Datenerfassung mit bahnbrechender SaaS-Lösung als integralem Bestandteil der Case-to-Closure-Plattform des Unternehmens	Mar. 26
Cellebrite révolutionne la collecte de données avec une solution SaaS révolutionnaire faisant partie intégrante de la plateforme Case-to-Closure de l’entreprise	Mar. 26
Cellebrite revolutioniert die Datenerfassung mit bahnbrechender SaaS-Lösung als integralem Bestandteil der Case-to-Closure-Plattform des Unternehmens	Mar. 26
Cellebrite DI Ltd. Announces the Appointment of David Gee as Chief Marketing Officer	Mar. 24
Cellebrite DI Ltd. Unveils Cellebrite Endpoint Inspector SaaS	Mar. 14
Cellebrite DI Shares Rise After William Blair Upgrades Stock to Outperform From Market Perform	Mar. 13
Cellebrite Launches FedRAMP Authorization Process for SaaS Offerings	Mar. 07
Cellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud Security	Mar. 07
Cellebrite Di Ltd Announces Retainment of Haim Shani as Director	Mar. 06
Cellebrite Sees Improved Business Momentum in 2024, BofA Securities Says	Feb. 16
Cellebrite DI's Q4 Adjusted Earnings, Revenue Gain; Sets Revenue Outlook for Q1, 2024	Feb. 15
Cellebrite DI Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15
Cellebrite DI Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15
Cellebrite DI Ltd. Provides Earnings Guidance for First-Quarter 2024 and Full Year 2024	Feb. 15
GNW-Adhoc: Cellebrite revolutioniert die Ermittlungsarbeit - und sorgt mit einer bahnbrechenden End-to-End-Plattform dafür, dass mehr Fälle schneller gelöst werden können	Jan. 25
Cellebrite révolutionne le flux de travail des enquêteurs avec une plateforme révolutionnaire, de bout en bout, pour résoudre plus rapidement davantage d’affaires	Jan. 25
Cellebrite revolutioniert die Ermittlungsarbeit – und sorgt mit einer bahnbrechenden End-to-End-Plattform dafür, dass mehr Fälle schneller gelöst werden können	Jan. 25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cellebrite DI Ltd.

Equities

CLBT

IL0011794802

Other languages

Filters